Accès gratuit
Numéro
Med Sci (Paris)
Volume 28, Mars 2012
Génomique et recherche clinique en oncologie : approches de sciences humaines, économiques et sociales (SHES)
Page(s) 28 - 32
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2012281s108
Publié en ligne 9 avril 2012
  1. Chabannon C, Lassailly F, Romain S, et al. Le réseau des centres de ressources biologiques (CRB) et tumorothèques de l’agglomération marseillaise. Med Sci (Paris) 2006 ; 22 (hors série n°1) : 26–31. [CrossRef] [EDP Sciences] [PubMed]
  2. Chabannon C, Honstettre A, Daufresne LM, et al. La publication de catalogues de collections d’échantillons biologiques par les tumorothèques. Bull Cancer 2010 ; 97 : 181–189. [PubMed]
  3. Reyrat E, Geneve J. Constitution d’un catalogue commun a plusieurs CRLCC : un projet de la FNCLCC. Med Sci (Paris) 2006 ; 22 (hors série n°1) : 35–38. [CrossRef] [EDP Sciences] [PubMed]
  4. Mancini J, Pellegrini I, Viret F, et al. Consent for biobanking: assessing the understanding and views of cancer patients. J Natl Cancer Inst 2011 ; 103 : 154–157. [CrossRef] [PubMed]
  5. Hall MA, Camacho F, Lawlor JS, et al. Measuring trust in medical researchers. Med Care 2006 ; 44 : 1048–1053. [CrossRef] [PubMed]
  6. Pellegrini I, Chabannon C, Mancini J, et al. Informed consent for biobanks and research: what make sense for cancer patients? Psychol Health 2009 ; 24 : 307–308.
  7. Mills EJ, Seely D, Rachlis B, et al. Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors. Lancet Oncol 2006 ; 7 : 141–148. [CrossRef] [PubMed]
  8. Jenkins V, Farewell D, Batt L, et al. The attitudes of 1066 patients with cancer towards participation in randomised clinical trials. Br J Cancer 2010 ; 103 : 1801–1807. [CrossRef] [PubMed]
  9. Julian-Reynier C, Geneve J, Dalenc F, et al. Assessment of care by breast cancer patients participating or not participating in a randomized controlled trial: a report with the Patients’ Committee for clinical trials of the Ligue nationale contre le cancer. J Clin Oncol 2007 ; 25 : 3038–3044. [CrossRef] [PubMed]
  10. Minasian LM, O’Mara AM. Accrual to clinical trials: let’s look at the physicians. J Natl Cancer Inst 2011 ; 103 : 357–358. [CrossRef] [PubMed]
  11. Ferguson PR. Patients’ experiences and views of clinical trials. Med Law 2001 ; 20 : 143–152. [PubMed]
  12. Mancini J, Geneve J, Dalenc F, et al. Decision-making and breast cancer clinical trials: how experience challenges attitudes. Contemp Clin Trials 2007 ; 28 : 684–694. [CrossRef] [PubMed]
  13. Brown RF, Shuk E, Leighl N, et al. Enhancing decision making about participation in cancer clinical trials: development of a question prompt list. Support Care Cancer 2010 ; 19 : 1227–1238. [CrossRef] [PubMed]
  14. Wendler D, Emanuel E. The debate over research on stored biological samples: what do sources think? Arch Intern Med 2002 ; 162 : 1457–1462. [CrossRef] [PubMed]
  15. Keogh B. European biobanks forge cross-border ties. J Natl Cancer Inst 2011 ; 103 : 1429–1431. [CrossRef] [PubMed]
  16. Kaphingst KA, Janoff JM, Harris LN, Emmons KM. Views of female breast cancer patients who donated biologic samples regarding storage and use of samples for genetic research. Clin Genet 006 ; 69 : 393–398.
  17. Axler RE, Irvine R, Lipworth W, et al. Why might people donate tissue for cancer research? Insights from organ/tissue/blood donation and clinical research. Pathobiology 2008 ; 75 : 323–329. [CrossRef] [PubMed]
  18. Allen J, McNamara B. Reconsidering the value of consent in biobank research. Bioethics 2011 ; 25 : 155–166. [CrossRef] [PubMed]
  19. Moutel G, de Montgolfier S, Meningaud JP, Herve C. Bio-libraries and DNA storage: assessment of patient perception of information. Med Law 2001 ; 20 : 193–204. [PubMed]
  20. Ormond KE, Cirino AL, Helenowski IB, et al. Assessing the understanding of biobank participants. Am J Med Genet 2009 ; 149A : 188–198. [CrossRef] [PubMed]
  21. Stevens T, Ahmedzai SH. Why do breast cancer patients decline entry into randomised trials and how do they feel about their decision later: a prospective, longitudinal, in-depth interview study. Patient Educ Couns 2004 ; 52 : 341–348. [CrossRef] [PubMed]
  22. Beardsley E, Jefford M, Mileshkin L. Longer consent forms for clinical trials compromise patient understanding: so why are they lengthening? J Clin Oncol 2007 ; 25 : e13–e14. [CrossRef] [PubMed]
  23. Stjernschantz Forsberg J, Hansson MG, Eriksson S. Biobank research: who benefits from individual consent? Br Med J 2011 ; 343 : d5647. [CrossRef] [PubMed]
  24. Vermeulen E, Schmidt MK, Aaronson NK, et al. A trial of consent procedures for future research with clinically derived biological samples. Br J Cancer 2009 ; 101 : 1505–1512. [CrossRef] [PubMed]
  25. Ransohoff DF, Gourlay ML. Sources of bias in specimens for research about molecular markers for cancer. J Clin Oncol 2010 ; 28 : 698–704. [CrossRef] [PubMed]
  26. Maraninchi D. Valeurs et valorisation des tumorothèques. Med Sci (Paris) 2006 ; 22 (hors série n°1) : 4. [CrossRef] [EDP Sciences] [PubMed]
  27. McMurter B, Parker L, Fraser RB, et al. Parental views on tissue banking in pediatric oncology patients. Pediatr Blood Cancer 2011 ; 57 :1217–1221. [CrossRef] [PubMed]
  28. Kaufman DJ, Murphy-Bollinger J, Scott J, Hudson KL. Public opinion about the importance of privacy in biobank research. Am J Hum Genet 2009 ; 85 : 643–654. [CrossRef] [PubMed]
  29. Watson RW, Kay EW, Smith D. Integrating biobanks: addressing the practical and ethical issues to deliver a valuable tool for cancer research. Nat Rev Cancer 2010 ; 10 : 646–651. [CrossRef] [PubMed]
  30. Skloot R. La vie immortelle d’Henrietta Lacks. Paris : Calmann-Lévy, 2011 : 440 p.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.